The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Ltd's promoter and promoter group members (Saurabh Goyal, Aryan Goyal, Payal Goyal, Smita Goyal, and Nectar Biopharma Pvt Ltd) have filed a Regulation 10(7) report with SEBI regarding their passive increase in voting rights following the company's recent buyback. The buyback ran from December 18 to December 24, 2025, at Rs. 330 per share, for a total size of up to Rs. 19.14 crore (5,80,000 shares). Promoters did not tender any shares, so their holding rose automatically from 64.97% to 68.09% as 4,58,255 public-held shares were extinguished. The report confirms no change in control, compliance with Regulation 10(4)(c) exemption, and timely filing (within 21 working days).
This is a passive increase in promoter stake caused by share cancellation in the buyback, not a fresh promoter purchase, so it does not signal any new buying interest. Shareholders should note that promoter holding has risen above 68%, reducing the free float further, which could weigh on trading liquidity going forward.